KAIST Develops AI That Automatically Designs Optimal Drug Candidates for Cancer-Targeting Mutations​ (IMAGE)

The Korea Advanced Institute of Science and Technology (KAIST)

KAIST Develops AI That Automatically Designs Optimal Drug Candidates for Cancer-Targeting Mutations​

Caption

<Figure 2. (Left) Target protein and the original bound molecule; (Right) Examples of molecules designed using the model developed in this study. The values for protein binding affinity (Vina), drug-likeness (QED), and synthetic accessibility (SA) are shown at the bottom.>

Credit

KAIST

Usage Restrictions

NO

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.